Short and long term impacts of COVID-19 on the pharmaceutical sector.
Daru
; 28(2): 799-805, 2020 Dec.
Article
in English
| MEDLINE | ID: covidwho-621499
ABSTRACT
BACKGROUND:
The novel coronavirus disease 2019 (COVID-19) was characterized as a global pandemic by the WHO on March 11th, 2020. This pandemic had major effects on the health market, the pharmaceutical sector, and was associated with considerable impacts; which may appear in short and long-term time-horizon and need identification and appropriate planning to reduce their socio-economic burden.OBJECTIVES:
Current short communication study assessed pharmaceutical market crisis during the COVID-19 era; discussing short- and long-term impacts of the pandemic on the pharmaceutical sector.RESULTS:
Short-term impacts of COVID-19 pandemic includes demand changes, regulation revisions, research and development process changes and the shift towards tele-communication and tele-medicine. In addition, industry growth slow-down, approval delays, moving towards self-sufficiency in pharm-production supply chain and trend changes in consumption of health-market products along with ethical dilemma could be anticipated as long-term impacts of COVID-19 pandemic on pharmaceutical sector in both global and local levels.CONCLUSION:
The pandemic of COVID-19 poses considerable crisis on the health markets, including the pharmaceutical sector; and identification of these effects, may guide policy-makers towards more evidence-informed planning to overcome accompanying challenges. Graphical abstract .Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Research
/
Pharmaceutical Preparations
/
Drug Industry
/
COVID-19
Type of study:
Experimental Studies
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
Daru
Year:
2020
Document Type:
Article
Affiliation country:
S40199-020-00358-5
Similar
MEDLINE
...
LILACS
LIS